
Valmet proposes a EUR 1.35 per-share dividend from 2025 profits (distributable equity EUR 1,625,144,488.08; net profit EUR 284,767,437.27; 2025 net sales ~EUR 5.2bn), paid in two instalments (EUR 0.68 on April 9, 2026, record date March 27; EUR 0.67 in October 2026 with proposed record date October 1 and payment October 7). The Board seeks authorization to repurchase up to 9.2 million shares (~5% of share capital) and to issue up to 18.5 million shares (~10%), reappoints PricewaterhouseCoopers as auditor and proposes increased board fees plus a requirement for directors to invest 40% of fixed annual fees in Valmet shares; total shares outstanding are 184,529,605 (including 297,175 treasury shares).
Market structure: Valmet’s AGM packages a EUR 1.35/share dividend (payable in April/Oct) and a 5% buyback authorization (9.2m shares) while also authorizing up to 10% share issuance (18.5m). Net profit €284.8m vs implied dividend cash ≈€249m (~87.5% payout) signals near-term cash return focus that should support the share price and reduce free float if buybacks are used, benefitting equity holders and suppliers of financing; competitors (e.g., Metso Outotec METSO:HE, Andritz ANDR:AV) may face relative underperformance if they don’t match capital returns. Risk assessment: Tail risks include a cyclical downturn in pulp/paper or missed M&A after share issuance, forcing dilutive raises; a 87% payout leaves limited buffer if 2026 orders drop >20%. Immediate risks (days–weeks): dividend record/ex-date mechanics (record Mar 27, AGM Mar 25). Medium/longer risks (months–years): material issuance used for equity-funded acquisitions (>5% issuance) could dilute EPS and offset buyback benefit. Trade implications: Direct plays favor taking a measured long in Valmet (VALMT:HE) into record date to capture yield, or buying post-ex-dividend on any pullback funded by announced buybacks. Relative-value: long VALMT vs short METSO (or ANDR) to express superior shareholder-return profile; use covered-call overlays around April to harvest premium while holding through Q2 order-intake updates. Contrarian angles: Consensus may underweight the downside of an aggressive payout—if orders slip, management may use the 10% issuance authority to dilute at unfavorable prices, an outcome markets often underprice. Conversely issuance authorization is frequently unused; if management executes >€100m buybacks within 6 months, upside could be underappreciated by 5–10% vs peers.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mildly positive
Sentiment Score
0.30